A blue background with circles and lines in the center.
A view of the town from above.

 

About Us: Redefining Wound Healing with BioHeal Hydrogel XG-100

At BIOHEAL THERAPEUTICS, we are redefining wound care with next-generation solutions that optimize healing. Our BioHeal Hydrogel, a tear-resistant, user-friendly alternative to traditional amnion sheets, is designed to simplify application, enhance durability, and save time for healthcare providers. (Note: BioHeal Hydrogel is currently in development and not yet available in the U.S.)

Pioneering Regenerative Medicine

Through an exclusive worldwide licensing agreement with the Wake Forest Institute for Regenerative Medicine (WFIRM), we harness cutting-edge amnion-derived technology to develop advanced wound care solutions. Our innovations are designed to:

  • Support wound closure and tissue repair
  • Enhance protection and healing for chronic wounds and burns

Expanding The Future of Wound Care 

We are continuously advancing our pipeline to:

  • Improve the wound care experience for patients and providers
  • Simplify product application with innovative formulations
  • Deliver cost-conscious solutions without compromising quality

Industry Leadership You Can Trust

Founded by Bruce Anderson and Steve Anderson, BIOHEAL THERAPEUTICS is built on 30+ years of experience in medical device development and human tissue processing. Our team has successfully commercialized implantable cardiovascular and orthopedic products, bringing life-changing technologies to market.

A Legacy of Innovation, Based in Greater Atlanta, Georgia

Headquartered in Greater Atlanta, Georgia, BIOHEAL THERAPEUTICS is committed to advancing regenerative medicine with practical, high-impact solutions designed to:

  • Revolutionize wound care applications
  • Support effective wound management and tissue regeneration

Join us in redefining wound care. Stay updated on our progress, or contact us to learn more. 

Meet the Team

Bruce Anderson

President & CEO

Bruce Anderson, cofounded BIOHEAL THERAPEUTICS in 2017, bringing over 20 years of global experience in developing, manufacturing, processing, and commercializing advanced surgical and regenerative medicine products.

Before launching BIOHEAL, Mr. Anderson played a key role in the success of BioGlue , the world's leading protein hydrogel surgical adhesive for cardiovascular surgery. He has also contributed to the development and commercialization of more than 20 implantable human cardiovascular and orthopedic tissues, along with multiple Class II and III medical devices.

In 2008, he was elected Vice President of US Sales and Global Marketing for Artivion (formerly CryoLife, Inc.), where he led a team of over 120 professionals across worldwide product marketing.  From 2002 to 2007, he served as Director of US Sales, driving double digit growth in the company's portfolio.

Mr. Anderson holds a degree from the University of South Florida at Tampa.

Steve Anderson (1939-2023): A Legacy of Innovation in Medical Devices

Steve Anderson was the Chairman of the Board and co-founder of BIOHEAL THERAPEUTICS, LLC, serving from its founding 2017 until his passing in 2023. A visionary entrepreneur and industry pioneer, he dedicated his career to advancing life-saving medical technologies.

Mr. Anderson was also the co-founder, President, CEO of CryoLife, Inc. (now Artivion) from 1984 - 2015. Under his leadership, the company went public on Nasdaq in 1994 and transitioned to the New York Stock Exchange in 1997.

Before founding CryoLife, he held key executive roles in the medical device industry:

A Legacy of Impact

CryoLife's cardiac tissues revolutionized pediatric reconstructive surgery, helping to save the lives of thousands of children, while its vascular tissues preserved the limbs of thousands of adults suffering from peripheral vascular disease. CryoLife’s products have reached 80 countries, and its cryopreserved human tissues and surgical adhesives have improved the lives of nearly 2 million people worldwide.

A true entrepreneur, pioneer, and leader in the medical device industry, Mr. Anderson’s contributions transformed cardiovascular surgery and tissue transplantation.

He was a graduate of the University of Minnesota at Minneapolis.